Group One Trading
WX

Group One Trading’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Group One Trading’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-59,159
Closed -$2.56M – 5529
2015
Q3 		$2.56M Buy
59,159
+27,171
+85% +$1.15M 0.04% 641
2015
Q2 		$1.35M Buy
+31,988
New +$1.35M 0.02% 995

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Group One Trading's WX Position: Q4 2015 in Review

Group One Trading sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 59,159 shares — an estimated $2.56M sold.

Group One Trading first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $2.56M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Group One Trading reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Group One Trading sold 59,159 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.56M.
  • Group One Trading first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
  • Group One Trading's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $2.56M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Group One Trading's 13F filing for Q4 2015, filed 11 Feb 2016.